Skip to main content
Premium Trial:

Request an Annual Quote

FDA Grants Emergency Use Authorization for KorvaLabs, GenoSensor Coronavirus Tests

NEW YORK — The US Food and Drug Administration on Thursday granted separate Emergency Use Authorizations for PCR-based SARS-CoV-2 tests developed by KorvaLabs and GenoSensor.

The Curative-Korva SARS-Cov-2 Assay — developed by Menlo Park, California-based KorvaLabs and San Dimas, California-based Curative — is designed to detect SARS-CoV-2 nucleic acid in oropharyngeal swab, nasopharyngeal swab, nasal swab, and oral fluid specimens. Its use is limited to KorvaLab.

Tempe, Arizona-based GenoSensor's GS COVID-19 RT-PCR kit is designed to detect SARS-CoV-2 nucleic acid in nasopharyngeal/oropharyngeal swab, nasal swab, and mid-turbinate swab specimens. It may be used by any CLIA-certified laboratory.

Both tests run on any authorized RT-PCR instrument, according to the FDA.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.